21 reports

  • 2 Epidemiology
  • 2.6.2 Limitations of the Analysis

Cancer; ##(##): ##-##.

  • Bladder Cancer
  • Japan
  • United Kingdom
  • United States
  • Forecast

Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Bladder Cancer
  • France
  • United States
  • World
  • Forecast

Europe Bladder Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Bladder Cancer
  • Europe
  • France
  • Germany
  • Forecast
  • REFERENCES

LIST OF CURRENT AND FUTURE EPIOMIC EPIDEMIOLOGY FORECAST REPORTS ##.

  • Bladder Cancer
  • Cancer
  • Pathology

Bladder Cancer Phase ## Clinical Trials, 2016 ##.

  • Bladder Cancer
  • France
  • Germany
  • United States
  • Market Size

However, NMIBCs are characterized by a high risk of recurrence, leading to a high disease burden and making bladder cancer one of the costliest malignancies to treat.

  • Bladder Cancer
  • European Union
  • Japan
  • United States
  • Market Size
  • 4 Epidemiology
  • BLADDER CANCER: KEY METRICS IN THE 7MM

Epidemiology; ##(##): ##-##.

  • Bladder Cancer
  • United States
  • Demand
  • Merck & Co., Inc.
  • OncoGenex Pharmaceuticals, Inc.

ABOUT THE AUTHORS Global Director of Therapy Analysis and Epidemiology Claire Herman, MPH is Global Director of Therapy Analysis and Epidemiology at GlobalData in Boston.

  • Bladder Cancer
  • United States
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group

Bladder Cancer Phase ## Clinical Trials, 2016 ##.

  • Bladder Cancer
  • France
  • Germany
  • Italy
  • Market Size

Bladder Cancer Phase ## Clinical Trials, 2016 ##.

  • Bladder Cancer
  • Cancer
  • Pathology
  • Japan
  • Market Size

Bladder Cancer Phase ## Clinical Trials, 2016 ##.

  • Bladder Cancer
  • Cancer
  • Pathology
  • United States
  • Market Size

Bladder Cancer Phase ## Clinical Trials, 2016 ##.

  • Bladder Cancer
  • Cancer
  • Pathology
  • United Kingdom
  • Market Size

Bladder Cancer Phase ## Clinical Trials, 2016 ##.

  • Bladder Cancer
  • Cancer
  • Pathology
  • Italy
  • Market Size

Bladder Cancer Phase ## Clinical Trials, 2016 ##.

  • Bladder Cancer
  • Cancer
  • Pathology
  • Germany
  • Market Size

Bladder Cancer Phase ## Clinical Trials, 2016 ##.

  • Bladder Cancer
  • Cancer
  • Pathology
  • France
  • Market Size

Bladder Cancer Phase ## Clinical Trials, 2016 ##.

  • Bladder Cancer
  • Cancer
  • Pathology
  • Spain
  • Market Size
  • Disease Overview and Epidemiology
  • Clinical Trial Activity in Bladder Cancer

Note: Data for Chinese epidemiology of glioblastoma is not available from GlobalData' s epidemiology and market size database.

  • Bladder Cancer
  • Breast Cancer
  • Epidemiology
  • Therapy
  • Product Initiative

Clinical Epidemiology; ##(##): ##-##. ##(##): ##-##. 2015, Orlando, Florida, US; Abstract ### Appendix Kohrt HE, et al. (2014).

  • Bladder Cancer
  • Oncology
  • Company
  • Demand
  • Product Initiative

Bladder Cancer: Disease and Pipeline Analysis Copyright and Usage Guidelines ## Table of Acronyms ## Chapter ## - Disease Overview ## Figure ##.

  • Bladder Cancer
  • Cancer
  • Pathology

Notably, while just one case was identified in 2010, ## cases were reported each year from 2013-2015.

  • Bladder Cancer
  • Blood Disease
  • Industrial Biotechnology
  • Nanobiotechnology
  • Nanosphere, Inc.

" As recognized authorities in medical practice, epidemiology and outcomes related to chronic kidney disease, they will provide invaluable clinical insight throughout the process.

  • Bladder Cancer
  • Cancer
  • United States
  • World
  • Metabolon, Inc.